CAROLINE SAM: Open Payments
NPI 1104440205 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$189 in 7 payments from 3 companies in 2025. Trend: 2023 $559 · 2024 $0 · 2025 $189
Food & beverage: $189
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 4 | $100 |
| Neurocrine BioSciences, Inc. | 2 | $52 |
| E.R. Squibb & Sons, L.L.C. | 1 | $37 |
Products named: UZEDY, INGREZZA, COBENFY.
Industry payments across SC — which companies pay providers there.
